Around 6 million Canadians will meet addiction during their lifetime, according to the Canadian Mental Health Association. With 22,828 total fatalities in Canada over a five year period, the opioid crisis marks one of the most extreme types of addiction. The fatality rate is rising year to year. Universal Ibogaine constantly working on a mission to transform...
This stock has completely shuttered the OTC and contributed to traffic gridlock in the morning rush. I'd make any effort to obtain this stock; therefore, for a favorable trade experience
$IBO is influencing auxiliary with fleetness on the TSX-V, as well as displaying a fantastic unit on the market, which was quite incredible! universalibogaine inc Path Forward Universal Ibogaine intends to acquire a network of addiction treatment clinics, licensing our treatment protocols to best in class treatment providers around the globe.
A billion stock trading for mere pennies in the market, I bought this highly exclusive stock $IBO a week ago and always had a satisfying experience ever since.
Julie Dumouchel has been named Director of Clinical Trials at UI, which is a significant strategic move. Julie Dumouchel has 25 years of experience in the pharmaceutical sector, where she has worked in a variety of clinical research jobs and has a thorough grasp of the drug development process.
$IBO has exceptional potential when it comes to volatility, and the share prices have been hiking lately, last closing of the stock trading at $0.0400 on TSX-V with a noted spike
$IBO don’t ever shy out from attaining peaks in the market and delivering unimaginable profit to the shareholders, the shares are trading yesterday with a massive spike of 11.11%, at $0.05 with substantial incline
$DIA, an exploration stage company, engages in the exploration and acquisition of mineral properties in Canada, and is currently trading at $0.1750, with a great jump in the market. As per the charts the stock is expected to follow a bullish pattern.
$IBO don’t ever shy out from attaining peaks in the market and delivering unimaginable profit to the shareholders, the shares are trading with a massive spike at $0.045 with substantial incline
$IBO is moving ahead with courage and compassion on the TSX-V, the stock is rising in leaps and bounds in the market, shares are effectively trading at $0.045 with a rise in value
$IBO has exceptional potential when it comes to volatility, and the share prices have been hiking lately,
$IBO is currently trading with enormous pace and is trying to disrupt its target price before time with every piece of effort it can foster, the shares are trading at $0.045 with volume of 24k
$IBO is currently trading with enormous pace and is trying to disrupt its target price before time with every piece of effort it can foster, the shares are trading at $0.05
Universal Ibogaine Inc. is a life science company with a mission to transform addiction treatment through the use of medicalized ibogaine and a global licensing model through a planned Canadian Clinical trial.
Universal Ibogaine Inc. holds a significant position over the TSX-V market with its greater difference between the lower and higher ranges of trading, which is $0.0400-$0.2500 in the last 52 weeks.
$IBO stock ticker to Universal Ibogaine a company that provides ibogaine addiction treatment to patients tormented from opioid addiction in Canada is currently trading rapidly at $0.0500 with no loss as such
The Frankfurt Stock Exchange (FSE) is Germany's largest stock exchange and the leading European destination for Canadian venture capital firms seeking exposure and liquidity in the European market. The FSE enables advanced electronic trading, settlement, and information technologies, allowing it to handle the increasing demands of cross-border trading.
$IBO has presented a rather magnificent momentum in the market and is moving up with a firm footing. Shares are trading at $0.05 per share with no noted loss percentage